Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Fluoxetine hydrochloride
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fluoxetine 20mg capsules
0403030E0AAAAAA
|
Fluoxetine hydrochloride | Fluoxetine hydrochloride | Central Nervous System | 532,495 |
|
Fluoxetine 40mg capsules
0403030E0AAANAN
|
Fluoxetine hydrochloride | Fluoxetine hydrochloride | Central Nervous System | 63,016 |
|
Fluoxetine 60mg capsules
0403030E0AAAEAE
|
Fluoxetine hydrochloride | Fluoxetine hydrochloride | Central Nervous System | 50,472 |
|
Fluoxetine 10mg capsules
0403030E0AAALAL
|
Fluoxetine hydrochloride | Fluoxetine hydrochloride | Central Nervous System | 50,280 |
|
Fluoxetine 30mg capsules
0403030E0AAAMAM
|
Fluoxetine hydrochloride | Fluoxetine hydrochloride | Central Nervous System | 35,876 |
|
Fluoxetine 20mg/5ml oral solution
0403030E0AAACAC
|
Fluoxetine hydrochloride | Fluoxetine hydrochloride | Central Nervous System | 28,445 |
|
Fluoxetine 20mg/5ml oral solution sugar free
0403030E0AAAHAH
|
Fluoxetine hydrochloride | Fluoxetine hydrochloride | Central Nervous System | 6,889 |
|
Fluoxetine 20mg dispersible tablets sugar free
0403030E0AAAKAK
|
Fluoxetine hydrochloride | Fluoxetine hydrochloride | Central Nervous System | 5,531 |
|
Fluoxetine 10mg tablets
0403030E0AAAPAP
|
Fluoxetine hydrochloride | Fluoxetine hydrochloride | Central Nervous System | 2,694 |
|
Fluoxetine 10mg/5ml oral suspension
0403030E0AAAQAQ
|
Fluoxetine hydrochloride | Fluoxetine hydrochloride | Central Nervous System | No data available |
|
Fluoxetine 2.5mg/5ml oral liquid
0403030E0AAAGAG
|
Fluoxetine hydrochloride | Fluoxetine hydrochloride | Central Nervous System | No data available |
|
Fluoxetine 20mg/5ml oral suspension
0403030E0AAARAR
|
Fluoxetine hydrochloride | Fluoxetine hydrochloride | Central Nervous System | No data available |
|
Fluoxetine 2mg/5ml oral liquid
0403030E0AAAIAI
|
Fluoxetine hydrochloride | Fluoxetine hydrochloride | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.